Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial
Simon Birk Kjær Jensen(University of Copenhagen), Signe S. Torekov(University of Copenhagen), Christian R. Juhl(University of Copenhagen), Lisa Olsen(University of Copenhagen), Sten Madsbad, Bente Stallknecht(University of Copenhagen), Jens J. Holst(University of Copenhagen), Charlotte Janus(University of Copenhagen), Rasmus Michael Sandsdal(University of Copenhagen), Martin Bæk Blond(University of Copenhagen), J. Lundgren(University of Copenhagen)
Cited by 171
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Low Physical Activity Accentuates the Effect of the <i>FTO</i> rs9939609 Polymorphism on Body Fat Accumulation
|Diabetes|2007|476
Impact of postprandial glycaemia on health and prevention of disease
|Obesity Reviews|2012|470
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
|New England Journal of Medicine|2021|469
Incretins, insulin secretion and Type 2 diabetes mellitus
|Diabetologia|2004|438